bioAffinity Technologies (BIAF) Competitors $0.29 -0.01 (-2.75%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$0.40 +0.11 (+38.03%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. RSLS, CISO, SJ, LUNA, DTST, XBP, MOBQ, FPAY, SWAG, and SCORShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ReShape Lifesciences (RSLS), CISO Global (CISO), Scienjoy (SJ), Luna Innovations (LUNA), Data Storage (DTST), XBP Europe (XBP), Mobiquity Technologies (MOBQ), FlexShopper (FPAY), Stran & Company, Inc. (SWAG), and comScore (SCOR). bioAffinity Technologies vs. Its Competitors ReShape Lifesciences CISO Global Scienjoy Luna Innovations Data Storage XBP Europe Mobiquity Technologies FlexShopper Stran & Company, Inc. comScore ReShape Lifesciences (NASDAQ:RSLS) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability. Does the media refer more to RSLS or BIAF? In the previous week, bioAffinity Technologies had 1 more articles in the media than ReShape Lifesciences. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 0.00 equaled bioAffinity Technologies'average media sentiment score. Company Overall Sentiment ReShape Lifesciences Neutral bioAffinity Technologies Neutral Which has preferable valuation & earnings, RSLS or BIAF? ReShape Lifesciences has higher earnings, but lower revenue than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReShape Lifesciences$8.01M0.77-$7.13M-$193.23-0.01bioAffinity Technologies$9.36M0.88-$9.04M-$0.72-0.40 Do analysts recommend RSLS or BIAF? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is RSLS or BIAF more profitable? ReShape Lifesciences has a net margin of -48.26% compared to bioAffinity Technologies' net margin of -110.53%. ReShape Lifesciences' return on equity of -251.90% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets ReShape Lifesciences-48.26% -251.90% -59.49% bioAffinity Technologies -110.53%-367.64%-154.15% Do insiders & institutionals have more ownership in RSLS or BIAF? 22.1% of ReShape Lifesciences shares are held by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are held by institutional investors. 0.0% of ReShape Lifesciences shares are held by insiders. Comparatively, 16.9% of bioAffinity Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, RSLS or BIAF? ReShape Lifesciences has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.53, suggesting that its share price is 153% more volatile than the S&P 500. SummarybioAffinity Technologies beats ReShape Lifesciences on 7 of the 13 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.48M$3.01B$5.56B$9.47BDividend YieldN/A2.41%4.31%4.17%P/E Ratio-0.4016.5729.3723.99Price / Sales0.88313.98444.7496.71Price / CashN/A42.1735.8458.51Price / Book1.707.818.085.58Net Income-$9.04M-$54.52M$3.26B$265.35M7 Day Performance-8.58%0.41%0.44%-0.07%1 Month Performance-1.13%9.93%4.82%1.76%1 Year Performance-83.15%15.18%30.27%25.39% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies0.3074 of 5 stars$0.29-2.8%N/A-83.9%$8.48M$9.36M-0.4010Upcoming EarningsRSLSReShape Lifesciences0.1983 of 5 stars$2.40-3.2%N/A-99.0%$5.92M$8.01M-0.0150Upcoming EarningsCISOCISO Global0.8541 of 5 stars$1.04-4.6%N/A+163.3%$35.65M$29.89M0.00443Upcoming EarningsSJScienjoy1.2152 of 5 stars$0.85-2.3%N/A-20.2%$34.00M$1.35B10.63280LUNALuna Innovations0.2146 of 5 stars$1.00flatN/A-61.7%$33.96M$116.61M0.00390Gap DownDTSTData Storage0.2785 of 5 stars$4.72+0.9%N/A+1.3%$33.42M$25.37M236.1260News CoverageUpcoming EarningsXBPXBP EuropeN/A$0.87-7.0%N/A-51.9%$33.40M$142.77M0.001,450Upcoming EarningsGap DownHigh Trading VolumeMOBQMobiquity Technologies0.5512 of 5 stars$1.40-0.7%N/A-42.6%$30.90M$1.24M-1.2510News CoverageUpcoming EarningsGap UpFPAYFlexShopper2.2996 of 5 stars$1.29flat$3.25+151.9%-33.8%$27.68M$139.80M-5.61140Gap DownSWAGStran & Company, Inc.0.9768 of 5 stars$1.60+8.1%N/A+27.7%$27.54M$82.65M-7.2770Upcoming EarningsGap UpHigh Trading VolumeSCORcomScore3.0111 of 5 stars$5.55-0.2%$10.75+93.7%-50.3%$27.51M$354.96M-0.351,200Trending News Related Companies and Tools Related Companies ReShape Lifesciences Competitors CISO Global Competitors Scienjoy Competitors Luna Innovations Competitors Data Storage Competitors XBP Europe Competitors Mobiquity Technologies Competitors FlexShopper Competitors Stran & Company, Inc. Competitors comScore Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
